Abstract
The World Health Organization (WHO) has developed a global health strategy to eliminate viral hepatitis. We project the treatment and prevention requirements to achieve the WHO HCV elimination target of reducing HCV incidence by 80% and HCV-related mortality by 65% by 2030 in Pakistan, which has the second largest HCV burden worldwide. We developed an HCV transmission model for Pakistan, and calibrated it to epidemiological data from a national survey (2007), surveys among people who inject drugs (PWID), and blood donor data. Current treatment coverage data came from expert opinion and published reports. The model projected the HCV burden, including incidence, prevalence and deaths through 2030, and estimated the impact of varying prevention and direct-acting antiviral (DAA) treatment interventions necessary for achieving the WHO HCV elimination targets. With no further treatment (currently ∼150 000 treated annually) during 2016-30, chronic HCV prevalence will increase from 3.9% to 5.1%, estimated annual incident infections will increase from 700 000 to 1 100 000, and 1 400 000 HCV-associated deaths will occur. To reach the WHO HCV elimination targets by 2030, 880 000 annual DAA treatments are required if prevention is not scal...Continue Reading
References
Aug 26, 1998·JAMA : the Journal of the American Medical Association
Dec 21, 2005·Journal of Viral Hepatitis·J M MicallefG J Dore
Sep 18, 2007·Lancet·Sania Nishtar
Jun 20, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hla-Hla TheinMurray D Krahn
Dec 5, 2009·World Journal of Gastroenterology : WJG·Yasir WaheedIshtiaq Qadri
Dec 17, 2009·Journal of Viral Hepatitis·N Z JanjuaS Hamid
Mar 20, 2010·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Mukesh Kumar KrishananiAli Khan Khuwaja
Aug 2, 2011·Lancet·Paul K NelsonLouisa Degenhardt
Mar 6, 2013·Annals of Internal Medicine·Rebecca L MorganYngve Falck-Ytter
Apr 5, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Natasha K MartinMatthew Hickman
Apr 10, 2014·Journal of Viral Hepatitis·H RazaviC Estes
Aug 3, 2014·Journal of Hepatology·Erin GowerHomie Razavi
Oct 2, 2014·Journal of Viral Hepatitis·A CousienY Yazdanpanah
Oct 12, 2014·The Lancet Global Health·Romulus BrebanArnaud Fontanet
Dec 3, 2014·Journal of Hepatology·Rachel H Westbrook, Geoffrey Dusheiko
Jan 7, 2015·Journal of Viral Hepatitis·A HatzakisH Razavi
Jan 24, 2015·Antiviral Research·Camilla S Graham, Tracy Swan
Aug 8, 2015·Current Opinion in HIV and AIDS·Natasha K MartinMatthew Hickman
Oct 30, 2015·Journal of Viral Hepatitis·A SibleyJ D Schmelzer
Mar 10, 2016·International Journal for Equity in Health· World Health OrganizationInke Mathauer
Jun 9, 2016·Liver International : Official Journal of the International Association for the Study of the Liver·Amr KandeelMaha Talaat
Oct 21, 2016·MMWR. Morbidity and Mortality Weekly Report·Lia GvinjiliaFrancisco Averhoff
Jan 1, 2017·Journal of Viral Hepatitis·H H Ayoub, L J Abu-Raddad
Apr 12, 2017·The Lancet. Gastroenterology & Hepatology·UNKNOWN European Union HCV Collaborators
Apr 14, 2017·The Lancet. Gastroenterology & Hepatology·UNKNOWN Polaris Observatory HCV Collaborators
Jul 27, 2017·Vaccine· World Health Organization
Sep 12, 2017·Addiction·Lucy PlattMatthew Hickman
Nov 17, 2017·The American Journal of Tropical Medicine and Hygiene·Adam TrickeyPeter Vickerman
Citations
Apr 4, 2019·PloS One·Asma AhsanSyed Shahzad-Ul-Hussan
May 11, 2019·JAMA Network Open·Jagpreet ChhatwalFasiha Kanwal
Sep 1, 2019·Journal of Internal Medicine·J V LazarusJ F Dillon
Aug 9, 2019·Journal of Viral Hepatitis·Adam TrickeyPeter Vickerman
Apr 13, 2019·Harm Reduction Journal·Andrew ScheibeHarry Hausler
Jan 15, 2020·Substance Use & Misuse·Lindsey HiebertScott A McDonald
May 28, 2019·BMJ Open·Houssein H Ayoub, Laith J Abu-Raddad
Jun 7, 2019·PloS One·Antoine ChaillonNatasha K Martin
Aug 29, 2019·BMC Health Services Research·Tomoyuki HayashiBenedetta Allegranzi
Aug 11, 2020·Journal of Gastroenterology and Hepatology·Antoine ChaillonNatasha K Martin
Sep 16, 2019·BMC Infectious Diseases·Sarwat MahmudLaith J Abu-Raddad
Mar 13, 2019·Hepatology Communications·Aaron G LimPeter Vickerman
Mar 5, 2020·Journal of Medical Virology·Saima MushtaqSobia Manzoor
Sep 29, 2020·Frontiers in Pharmacology·Saima MushtaqSobia Manzoor
Nov 8, 2018·Medicina·Saba Khaliq, Syed Mohsin Raza
Jan 1, 2019·International Health·Gul Ghuttai KhalidRafael Van den Bergh
Oct 22, 2019·Lancet·C Wendy SpearmanMark Sonderup
Feb 4, 2021·Journal of Family Medicine and Primary Care·Annum IshtiaqHiba Ashraf
Oct 15, 2020·Journal of Viral Hepatitis·Nyashadzaishe MafirakurevaJosephine G Walker
Feb 26, 2021·BMJ Global Health·Lara K MarquezNatasha K Martin
Mar 14, 2020·The International Journal on Drug Policy·Lara K MarquezNatasha K Martin
Apr 3, 2021·Journal of Viral Hepatitis·Blessing DzingiraiNyashadzaishe Mafirakureva
Apr 16, 2021·The Lancet. Gastroenterology & Hepatology·Matthew J AkiyamaUNKNOWN International Network on Health and Hepatitis in Substance Users–Prisons Network
Aug 28, 2021·Archives of Virology·Javeria Rafique RaoMuhammad Idrees
Oct 20, 2021·PLoS Medicine·Aaron G LimPeter Vickerman
Dec 11, 2021·Medicine·Muhammad Rashid, Hammad Ismail
Dec 23, 2019·The Lancet Global Health·Josephine G WalkerPeter Vickerman
Jan 1, 2022·BMC Public Health·Sidra MaqsoodFlorian Fischer